63307-08-4 Usage
Uses
Used in Fragrance Industry:
ETHYL 3-(3,4-DIMETHOXYPHENYL)PROPIONATE is used as a fragrance ingredient for its ability to impart a pleasant and complex scent to various products. It contributes to the development of perfumes, enhancing their olfactory profile with its fruity and floral notes.
Used in Flavor Industry:
In the flavor industry, ETHYL 3-(3,4-DIMETHOXYPHENYL)PROPIONATE is used as a flavoring agent to add depth and character to food and beverages, particularly those seeking a natural, fruity, or floral taste.
Used in Cosmetics Industry:
ETHYL 3-(3,4-DIMETHOXYPHENYL)PROPIONATE is used as a scent component in the manufacturing of soaps and lotions, where it provides a desirable aroma and contributes to the overall sensory experience of these products.
Used as an Intermediate in Organic Synthesis:
Beyond its direct applications, ETHYL 3-(3,4-DIMETHOXYPHENYL)PROPIONATE also serves as a valuable intermediate in organic synthesis, enabling the creation of a range of other chemical compounds for various industrial applications.
Check Digit Verification of cas no
The CAS Registry Mumber 63307-08-4 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 6,3,3,0 and 7 respectively; the second part has 2 digits, 0 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 63307-08:
(7*6)+(6*3)+(5*3)+(4*0)+(3*7)+(2*0)+(1*8)=104
104 % 10 = 4
So 63307-08-4 is a valid CAS Registry Number.
InChI:InChI=1/C13H18O4/c1-4-17-12(14)9-8-10-6-5-7-11(15-2)13(10)16-3/h5-7H,4,8-9H2,1-3H3
63307-08-4Relevant articles and documents
OCTAHYDROBENZO[F]QUINOLINE-BASED RECEPTOR AGONISTS AND ANTAGONISTS
-
, (2008/06/13)
The present invention relates to a composition, and method of use, of an octahydrobenzo[f]quinoline-based compound represented by structural formula (I). In this formula, R 1 is--OH or--OCH 3 and R 2 is--H,--OH or--OCH 3. In addition, R 3 is a C1 to C2 saturated or unsaturated, alkyl group. Furthermore, R 4 is an aryl group, wherein examples of suitable aryl groups, as defined herein, include phenyl and thienyl groups. The method of this invention relates to the use of the claimed compositions to treat psychotic disorders, to treat Parkinson's disease, or to sedate a mammal by administering an effective amount of a claimed composition.
